1 – 22 of 22
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
How proven is a 'proven intervention'? Ethics of placebo controls in light of conditional approval programs
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Bringing Advanced Therapies for Parkinson's Disease to the Clinic : An Analysis of Ethical Issues
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Understanding voluntariness of consent in first-in-human cell therapy trials
(
- Contribution to journal › Article
- 2017
-
Mark
The ethics of withdrawal : The case of follow-up from first-in-human clinical trials
(
- Contribution to journal › Article
-
Mark
Challenges to informed consent in first-in-human trials involving novel treatments: A case study of Parkinson’s disease
(
- Contribution to journal › Article
- 2014
-
Mark
Cell therapies for Parkinson's disease
(
- Contribution to journal › Article
- 2013
-
Mark
Differences Between Parkinson's and Huntington's Diseases and Their Role for Prioritization of Stem Cell-Based Treatments
(
- Contribution to journal › Article
- 2012
-
Mark
Withdrawal from Biobank Research: Considerations and the Way Forward.
2012) In Stem Cell Reviews and Reports(
- Contribution to journal › Article
-
Mark
Which patient groups should be asked to participate in first-in-human trials of stem-cell-based therapies?
(
- Contribution to journal › Article
-
Mark
Building the Bridge from Bench to Bedside: Ethical Issues in Translational Stem Cell Research
(
- Thesis › Doctoral thesis (compilation)
- 2011
-
Mark
TWENTY YEARS OF HUMAN RESEARCH ETHICS COMMITTEES IN THE BALTIC STATES.
(
- Contribution to journal › Article
-
Mark
Do we Still Need Human Embryonic Stem Cells for Stem Cell-Based Therapies? Epistemic and Ethical Aspects.
(
- Contribution to journal › Article
-
Mark
Experimental Stem-Cell Based Therapy in Pediatrics : A Fictional Case Study
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2010
-
Mark
Non-equivalent stringency of ethical review in the Baltic States: a sign of a systematic problem in Europe?
(
- Contribution to journal › Article
- 2009
-
Mark
Banks, Repositories and Registries of Stem Cell Lines in Europe: Regulatory and Ethical Aspects.
(
- Contribution to journal › Article
-
Mark
Research on Human-animal Entities: Ethical and Regulatory Aspects in Europe.
(
- Contribution to journal › Article
- 2008
-
Mark
Motivation to donate or not donate surplus embryos for stem-cell research: literature review
(
- Contribution to journal › Scientific review
-
Mark
Decisions to donate surplus embryos - Reply
(
- Contribution to journal › Letter
-
Mark
Genetically modified organisms: do the benefits outweigh the risks?
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Therapeutic perspectives of human embryonic stem cell research versus the moral status of a human embryo – does one have to be compromised for the other?
2007)(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2006
-
Mark
Therapeutic perspectives of human embryonic stem cell research versus the moral status of a human embryo – does one have to be compromised for the other?
(
- Contribution to journal › Article
- 2005
-
Mark
Sources of human embryos for stem cell research: ethical problems and their possible solutions.
(
- Contribution to journal › Article